Ophthalmology has been looking to address this unmet need for a long time. TearClear is developing a simple and effective technology that will truly benefit the patient.

BAK has been shown to be a significant cause of a host of adverse events with prolonged use… TearClear’s technology offers a compelling and differentiated approach to eliminating the preservative before delivery while allowing it to preserve sterility within the bottle.

My bet is that TearClear is the transformative product of OIS/AAO 2019.